S&P 500   2,998.47 (+0.08%)
DOW   26,810.43 (+0.08%)
QQQ   191.67 (-0.10%)
AAPL   242.39 (+1.01%)
FB   184.39 (+1.12%)
MSFT   135.93 (-0.32%)
GOOGL   1,248.50 (+0.59%)
AMZN   1,754.93 (-0.61%)
NVDA   194.83 (-0.40%)
MU   44.43 (-0.52%)
AMD   31.48 (-0.10%)
GILD   66.21 (+0.53%)
DIS   131.17 (-0.93%)
S&P 500   2,998.47 (+0.08%)
DOW   26,810.43 (+0.08%)
QQQ   191.67 (-0.10%)
AAPL   242.39 (+1.01%)
FB   184.39 (+1.12%)
MSFT   135.93 (-0.32%)
GOOGL   1,248.50 (+0.59%)
AMZN   1,754.93 (-0.61%)
NVDA   194.83 (-0.40%)
MU   44.43 (-0.52%)
AMD   31.48 (-0.10%)
GILD   66.21 (+0.53%)
DIS   131.17 (-0.93%)
Log in

Dermira News Headlines (NASDAQ:DERM)

$7.03
-0.32 (-4.35 %)
(As of 10/23/2019 12:13 PM ET)
Today's Range
$6.94
Now: $7.03
$7.45
50-Day Range
$5.31
MA: $7.17
$9.35
52-Week Range
$5.25
Now: $7.03
$15.48
Volume797,386 shs
Average Volume1.47 million shs
Market Capitalization$382.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

Headlines

Dermira (NASDAQ DERM) News Headlines

Source:
DateHeadline
 Brokerages Expect Dermira Inc (NASDAQ:DERM) Will Announce Quarterly Sales of $11.07 Million Brokerages Expect Dermira Inc (NASDAQ:DERM) Will Announce Quarterly Sales of $11.07 Million
www.americanbankingnews.com - October 22 at 2:42 AM
 Analysts Anticipate Dermira Inc (NASDAQ:DERM) Will Announce Earnings of -$1.40 Per Share Analysts Anticipate Dermira Inc (NASDAQ:DERM) Will Announce Earnings of -$1.40 Per Share
www.americanbankingnews.com - October 20 at 5:24 PM
Dermira Inc (NASDAQ:DERM) Receives Average Rating of "Buy" from AnalystsDermira Inc (NASDAQ:DERM) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - October 20 at 7:46 AM
Heres Why Dermira Stock Is Rocketing Higher Today - Motley FoolHere's Why Dermira Stock Is Rocketing Higher Today - Motley Fool
www.fool.com - October 18 at 5:37 PM
Dermira and Nuvectra among healthcare gainers; Mirati Therapeutics leads the losers - Seeking AlphaDermira and Nuvectra among healthcare gainers; Mirati Therapeutics leads the losers - Seeking Alpha
seekingalpha.com - October 18 at 12:36 PM
Dermira up 29% on additional mid-stage data on dermatitis med lebrikizumab - Seeking AlphaDermira up 29% on additional mid-stage data on dermatitis med lebrikizumab - Seeking Alpha
seekingalpha.com - October 18 at 12:36 PM
Dermiras (DERM) Buy Rating Reaffirmed at Needham & Company LLCDermira's (DERM) Buy Rating Reaffirmed at Needham & Company LLC
www.americanbankingnews.com - October 18 at 8:07 AM
Dermira (DERM) Highlights Data from Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis - StreetInsider.comDermira (DERM) Highlights Data from Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis - StreetInsider.com
www.streetinsider.com - October 18 at 7:36 AM
Dermira Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference - Business WireDermira Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference - Business Wire
www.businesswire.com - October 17 at 6:49 PM
Dermira Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology ConferenceDermira Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference
finance.yahoo.com - October 17 at 6:49 PM
Why You Should Watch Nektar Therapeutics and Dermira - Baystreet.caWhy You Should Watch Nektar Therapeutics and Dermira - Baystreet.ca
www.baystreet.ca - October 16 at 5:01 PM
Dermira Starts Lebrikizumab Dosing in Late-Stage Eczema Study - Yahoo FinanceDermira Starts Lebrikizumab Dosing in Late-Stage Eczema Study - Yahoo Finance
finance.yahoo.com - October 10 at 2:13 PM
Dermira to Present Data from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis at Fall Clinical Dermatology Conference - Business WireDermira to Present Data from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis at Fall Clinical Dermatology Conference - Business Wire
www.businesswire.com - October 10 at 2:13 PM
Dermira to Present Data from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis at Fall Clinical Dermatology Conference - Yahoo FinanceDermira to Present Data from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis at Fall Clinical Dermatology Conference - Yahoo Finance
finance.yahoo.com - October 10 at 9:12 AM
Dermira to Present Data from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis at Fall Clinical Dermatology ConferenceDermira to Present Data from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis at Fall Clinical Dermatology Conference
finance.yahoo.com - October 10 at 9:12 AM
BRIEF-Dermira Says Initiation Of First Phase 3 Clinical Study In Lebrikizumab Phase 3 Development Program Triggers A $7.5 Mln Milestone Payment By Almirall - ReutersBRIEF-Dermira Says Initiation Of First Phase 3 Clinical Study In Lebrikizumab Phase 3 Development Program Triggers A $7.5 Mln Milestone Payment By Almirall - Reuters
www.reuters.com - October 9 at 12:25 PM
Dermira up 3% premarket on start of late-stage development of lebrikizumab - Seeking AlphaDermira up 3% premarket on start of late-stage development of lebrikizumab - Seeking Alpha
seekingalpha.com - October 9 at 12:25 PM
Dermira Announces Initiation of Phase 3 Program Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic DermatitisDermira Announces Initiation of Phase 3 Program Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis
finance.yahoo.com - October 9 at 12:25 PM
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo FinanceDermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
finance.yahoo.com - October 9 at 7:25 AM
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - October 8 at 7:38 PM
Dermira Inc (NASDAQ:DERM) Expected to Announce Quarterly Sales of $11.07 MillionDermira Inc (NASDAQ:DERM) Expected to Announce Quarterly Sales of $11.07 Million
www.americanbankingnews.com - September 30 at 6:37 AM
-$1.40 EPS Expected for Dermira Inc (NASDAQ:DERM) This Quarter-$1.40 EPS Expected for Dermira Inc (NASDAQ:DERM) This Quarter
www.americanbankingnews.com - September 28 at 2:27 AM
Dermira to Participate in the 2019 Cantor Global Healthcare Conference - Yahoo FinanceDermira to Participate in the 2019 Cantor Global Healthcare Conference - Yahoo Finance
finance.yahoo.com - September 26 at 8:40 PM
Dermira to Participate in the 2019 Cantor Global Healthcare ConferenceDermira to Participate in the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 26 at 8:40 PM
How Much Are Dermira, Inc. (NASDAQ:DERM) Insiders Spending On Buying Shares? - Yahoo FinanceHow Much Are Dermira, Inc. (NASDAQ:DERM) Insiders Spending On Buying Shares? - Yahoo Finance
finance.yahoo.com - September 11 at 2:39 PM
How Much Are Dermira, Inc. (NASDAQ:DERM) Insiders Spending On Buying Shares?How Much Are Dermira, Inc. (NASDAQ:DERM) Insiders Spending On Buying Shares?
finance.yahoo.com - September 11 at 2:38 PM
Dermira to Participate in Upcoming Investor Conferences - Yahoo FinanceDermira to Participate in Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - August 29 at 7:39 PM
Dermira to Participate in Upcoming Investor ConferencesDermira to Participate in Upcoming Investor Conferences
finance.yahoo.com - August 29 at 7:39 PM
Dermira Inc (DERM) CEO & Chairman of the Board Thomas G Wiggans Bought $199,998 of Shares - Yahoo FinanceDermira Inc (DERM) CEO & Chairman of the Board Thomas G Wiggans Bought $199,998 of Shares - Yahoo Finance
finance.yahoo.com - August 20 at 11:30 AM
Dermira, Inc. (DERM) CEO Tom Wiggans on Q2 2019 Results - Earnings Call Transcript - Seeking AlphaDermira, Inc. (DERM) CEO Tom Wiggans on Q2 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 10 at 11:26 AM
Edited Transcript of DERM earnings conference call or presentation 7-Aug-19 8:30pm GMT - Yahoo FinanceEdited Transcript of DERM earnings conference call or presentation 7-Aug-19 8:30pm GMT - Yahoo Finance
finance.yahoo.com - August 9 at 1:32 AM
Edited Transcript of DERM earnings conference call or presentation 7-Aug-19 8:30pm GMTEdited Transcript of DERM earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 9 at 1:32 AM
Dermira Reports Second Quarter 2019 Financial Results and Provides Corporate Update - Business WireDermira Reports Second Quarter 2019 Financial Results and Provides Corporate Update - Business Wire
www.businesswire.com - August 8 at 10:41 AM
Dermira (DERM) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceDermira (DERM) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - August 7 at 10:19 PM
Dermira to Report Second Quarter 2019 Results and Host Conference Call on Wednesday, August 7, 2019Dermira to Report Second Quarter 2019 Results and Host Conference Call on Wednesday, August 7, 2019
finance.yahoo.com - August 2 at 12:04 AM
Dermira to Report Second Quarter 2019 Results and Host Conference Call on Wednesday, August 7, 2019 - Yahoo FinanceDermira to Report Second Quarter 2019 Results and Host Conference Call on Wednesday, August 7, 2019 - Yahoo Finance
finance.yahoo.com - August 1 at 10:22 AM
Earnings Preview: Dermira (DERM) Q2 Earnings Expected to Decline - NasdaqEarnings Preview: Dermira (DERM) Q2 Earnings Expected to Decline - Nasdaq
www.nasdaq.com - July 29 at 11:47 PM
Earnings Preview: Dermira (DERM) Q2 Earnings Expected to Decline - Yahoo FinanceEarnings Preview: Dermira (DERM) Q2 Earnings Expected to Decline - Yahoo Finance
finance.yahoo.com - July 29 at 11:58 AM
Earnings Preview: Dermira (DERM) Q2 Earnings Expected to DeclineEarnings Preview: Dermira (DERM) Q2 Earnings Expected to Decline
finance.yahoo.com - July 29 at 11:58 AM
Should You Be Pleased About The CEO Pay At Dermira, Inc.s (NASDAQ:DERM) - Yahoo FinanceShould You Be Pleased About The CEO Pay At Dermira, Inc.'s (NASDAQ:DERM) - Yahoo Finance
finance.yahoo.com - July 25 at 11:28 AM
Should You Be Pleased About The CEO Pay At Dermira, Inc.'s (NASDAQ:DERM)Should You Be Pleased About The CEO Pay At Dermira, Inc.'s (NASDAQ:DERM)
finance.yahoo.com - July 24 at 11:01 PM
Stocks Soar 7% in JuneStocks Soar 7% in June
finance.yahoo.com - July 1 at 6:31 PM
Dermira up 9% premarket on Abbvie/Allergan deal - Seeking AlphaDermira up 9% premarket on Abbvie/Allergan deal - Seeking Alpha
seekingalpha.com - June 25 at 11:27 AM
Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis - Yahoo FinanceAlmirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis - Yahoo Finance
finance.yahoo.com - June 25 at 11:27 AM
Five Prime Therapeutics Appoints Lori Lyons-Williams to its Board of Directors - Yahoo FinanceFive Prime Therapeutics Appoints Lori Lyons-Williams to its Board of Directors - Yahoo Finance
finance.yahoo.com - June 24 at 4:22 PM
Yeti Holdings, Canopy Growth, Dermira: Mad Money Lightning Round - TheStreetYeti Holdings, Canopy Growth, Dermira: 'Mad Money' Lightning Round - TheStreet
www.thestreet.com - June 12 at 11:03 AM
Dermira to Present at the Raymond James Life Sciences and MedTech Conference - Yahoo FinanceDermira to Present at the Raymond James Life Sciences and MedTech Conference - Yahoo Finance
finance.yahoo.com - June 11 at 6:57 PM
Dermira to Present at the Raymond James Life Sciences and MedTech ConferenceDermira to Present at the Raymond James Life Sciences and MedTech Conference
finance.yahoo.com - June 11 at 6:57 PM
Benzingas Top Upgrades, Downgrades For June 6, 2019 - BenzingaBenzinga's Top Upgrades, Downgrades For June 6, 2019 - Benzinga
www.benzinga.com - June 6 at 6:46 PM
Mizuho likes Dermira, shares up 3% premarket - Seeking AlphaMizuho likes Dermira, shares up 3% premarket - Seeking Alpha
seekingalpha.com - June 6 at 6:46 PM
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Featured Article: Convertible Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel